• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 相关的卵巢早衰:病例报告及文献复习。

COVID-19-related premature ovarian insufficiency: case report and literature review.

机构信息

Department of Obstetrics and Gynecology, Institute of Mother and Child, Warsaw, Poland.

Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.

出版信息

Climacteric. 2023 Dec;26(6):601-604. doi: 10.1080/13697137.2023.2246878. Epub 2023 Aug 30.

DOI:10.1080/13697137.2023.2246878
PMID:37647929
Abstract

OBJECTIVE

The aim of this study is to present the case report of a 36-year-old woman developing premature ovarian insufficiency (POI) after COVID-19 and review the literature referring to the possible impact of SARS-CoV-2 infection on female reproduction.

METHODS

A 36-year-old nulligravida with normal menstrual cycles, non-smoker, with a normal body mass index and no pelvic surgery or oncological treatment in her medical history presented to the Infertility Center of the Institute of Mother and Child in Warsaw after a year of unsuccessful attempts to get pregnant. During diagnostic process she was affected by COVID-19 with a mild manifestation and thereafter she presented amenorrhea with intense hot flushes. Further diagnostic confirmed the diagnosis of POI.

RESULTS

There is a strong molecular basis for a possible effect of SARS-CoV-2 infection on the female reproductive system; however, the results of available research are conflicting. All of these aspects are discussed in detail.

CONCLUSIONS

SARS-CoV-2 infection may cause serious complications that cast a long shadow on a patient's future life and health. Further research is needed to assess the real impact of SARS-CoV-2 infection on female reproductive health, as well as potential preventive and therapeutic strategies for women affected with COVID-19.

摘要

目的

本研究旨在报告一例 COVID-19 后发生卵巢早衰(POI)的 36 岁女性病例,并回顾文献中提到的 SARS-CoV-2 感染对女性生殖可能产生的影响。

方法

一名 36 岁的初产妇,月经周期正常,不吸烟,体重指数正常,无盆腔手术或肿瘤治疗史,因一年未孕来华沙母婴研究所不孕中心就诊。在诊断过程中,她感染了 COVID-19,表现为轻症,此后出现闭经和严重的热潮红。进一步的诊断证实了 POI 的诊断。

结果

SARS-CoV-2 感染对女性生殖系统可能产生影响有很强的分子基础,但现有研究结果存在矛盾。详细讨论了所有这些方面。

结论

SARS-CoV-2 感染可能导致严重并发症,对患者未来的生活和健康产生长期影响。需要进一步研究以评估 SARS-CoV-2 感染对女性生殖健康的真实影响,以及针对 COVID-19 感染女性的潜在预防和治疗策略。

相似文献

1
COVID-19-related premature ovarian insufficiency: case report and literature review.COVID-19 相关的卵巢早衰:病例报告及文献复习。
Climacteric. 2023 Dec;26(6):601-604. doi: 10.1080/13697137.2023.2246878. Epub 2023 Aug 30.
2
Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement.关于长新冠患者评估与治疗的多学科协作指南:一份概要声明
PM R. 2025 Apr 22. doi: 10.1002/pmrj.13397.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
5
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
8
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
9
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
10
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.

引用本文的文献

1
Changing Etiological Spectrum of Premature Ovarian Insufficiency over the Past Decades: A Comparative Analysis of Two Cohorts from a Single Center.过去几十年卵巢早衰病因谱的变化:来自单一中心的两个队列的比较分析
Diagnostics (Basel). 2025 Jul 6;15(13):1724. doi: 10.3390/diagnostics15131724.